
Open Labs Key to Cracking Toughest Health Problems?
The Policy Innovations website noted that there’s now a growing consensus that the open innovation approach is key to tackling disease in the developing world. GlaxoSmithKline’s (GSK) Open Lab has turned the traditional research and development (R&D) model of closed innovation—of companies working behind closed doors and guarding the
Comments Off on Open Labs Key to Cracking Toughest Health Problems? • Read this story »